发明名称 TREATMENT OF OCULAR NEOVASCULAR DISORDERS SUCH AS MACULAR DEGENERATION, ANGIOD STREAKS, UVEITIS AND MACULAR EDEMA
摘要 <p>The present invention is directed to methods of treating an ocular neovascular disorder in a mammal by administration of pyrimidine derivatives, benzodiazepinyl derivatives and pharmaceutical compositions containing the same. The invention encompasses methods of treating an ocular neovascular disorder by administration of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, (S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or salts or solvates thereof. Combination therapies for the treatment of ocular neovascular disorders are also encompassed.</p>
申请公布号 PT1968594(E) 申请公布日期 2010.11.18
申请号 PT20060838635T 申请日期 2006.11.29
申请人 GLAXOSMITHKLINE LLC 发明人 RICHARD ANTHONY BRIGANDI;MARK LEVICK;WILLIAM HENRY MILLER
分类号 A61K31/506;A61K31/55;A61P27/02 主分类号 A61K31/506
代理机构 代理人
主权项
地址